155 related articles for article (PubMed ID: 3202898)
1. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine enantiomers and two putative metabolites--I. Effect on reduced glutathione, methemoglobin content and release of hemoglobin.
Agarwal S; Gupta UR; Gupta RC; Anand N; Agarwal SS
Biochem Pharmacol; 1988 Dec; 37(24):4605-9. PubMed ID: 3202898
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of glucose-6-phosphate dehydrogenase deficient red cells to primaquine, primaquine enantiomers, and its two putative metabolites. II. Effect on red blood cell membrane, lipid peroxidation, MC-540 staining, and scanning electron microscopic studies.
Agarwal S; Gupta UR; Daniel CS; Gupta RC; Anand N; Agarwal SS
Biochem Pharmacol; 1991 Jan; 41(1):17-21. PubMed ID: 1986741
[TBL] [Abstract][Full Text] [Related]
3. Effects of nine synthetic putative metabolites of primaquine on activity of the hexose monophosphate shunt in intact human red blood cells in vitro.
Baird JK; McCormick GJ; Canfield CJ
Biochem Pharmacol; 1986 Apr; 35(7):1099-106. PubMed ID: 3754446
[TBL] [Abstract][Full Text] [Related]
4. Effects of metabolites of primaquine and acetanilid on normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Fraser IM; Vesell ES
J Pharmacol Exp Ther; 1968 Jul; 162(1):155-65. PubMed ID: 5656594
[No Abstract] [Full Text] [Related]
5. Studies on the mechanisms of oxidation in the erythrocyte by metabolites of primaquine.
Fletcher KA; Barton PF; Kelly JA
Biochem Pharmacol; 1988 Jul; 37(13):2683-90. PubMed ID: 2839199
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of certain hydroxy analogues of the antimalarial drug primaquine and their in vitro methemoglobin-producing and glutathione-depleting activity in human erythrocytes.
Allahyari R; Strother A; Fraser IM; Verbiscar AJ
J Med Chem; 1984 Mar; 27(3):407-10. PubMed ID: 6699888
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of rutin against hemoglobin oxidation.
Grinberg LN; Rachmilewitz EA; Newmark H
Biochem Pharmacol; 1994 Aug; 48(4):643-9. PubMed ID: 8080436
[TBL] [Abstract][Full Text] [Related]
8. Primaquine-induced hemolytic anemia: susceptibility of normal versus glutathione-depleted rat erythrocytes to 5-hydroxyprimaquine.
Bowman ZS; Oatis JE; Whelan JL; Jollow DJ; McMillan DC
J Pharmacol Exp Ther; 2004 Apr; 309(1):79-85. PubMed ID: 14724225
[TBL] [Abstract][Full Text] [Related]
9. Alterations in normal and G-6-PD deficient human erythrocytes of various ages after exposure to metabolites of hemolytic drugs.
Fraser IM; Tilton BE; Vesell ES
Pharmacology; 1971; 5(3):173-87. PubMed ID: 5119006
[No Abstract] [Full Text] [Related]
10. Oxidative activity of hydroxylated primaquine analogs. Non-toxicity to glucose-6-phosphate dehydrogenase-deficient human red blood cells in vitro.
Baird JK; Davidson DE; Decker-Jackson JE
Biochem Pharmacol; 1986 Apr; 35(7):1091-8. PubMed ID: 3754445
[TBL] [Abstract][Full Text] [Related]
11. NADPH, not glutathione, status modulates oxidant sensitivity in normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Scott MD; Zuo L; Lubin BH; Chiu DT
Blood; 1991 May; 77(9):2059-64. PubMed ID: 2018843
[TBL] [Abstract][Full Text] [Related]
12. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study.
Alanazi FK; Harisa Gel-D; Maqboul A; Abdel-Hamid M; Neau SH; Alsarra IA
Arch Pharm Res; 2011 Apr; 34(4):563-71. PubMed ID: 21544721
[TBL] [Abstract][Full Text] [Related]
13. Oxidation of glutathione by methylene blue is equivalent in G-6-PD deficient and normal erythrocytes.
Kelner MJ; Alexander NM
Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):265-8. PubMed ID: 3715203
[No Abstract] [Full Text] [Related]
14. Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates.
Link CM; Theoharides AD; Anders JC; Chung H; Canfield CJ
Toxicol Appl Pharmacol; 1985 Nov; 81(2):192-202. PubMed ID: 4060148
[TBL] [Abstract][Full Text] [Related]
15. Primaquine-mediated oxidative metabolism in the human red cell. Lack of dependence on oxyhemoglobin, H2O2 formation, or glutathione turnover.
Kelman SN; Sullivan SG; Stern A
Biochem Pharmacol; 1982 Jul; 31(14):2409-14. PubMed ID: 7126253
[TBL] [Abstract][Full Text] [Related]
16. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway.
Ganesan S; Chaurasiya ND; Sahu R; Walker LA; Tekwani BL
Toxicology; 2012 Mar; 294(1):54-60. PubMed ID: 22330256
[TBL] [Abstract][Full Text] [Related]
17. The effect of methyl oleate hydroperoxide, a possible toxic ozone intermediate, on human normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes.
Williams P; Calabrese EJ; Moore GS
Ecotoxicol Environ Saf; 1983 Apr; 7(2):242-8. PubMed ID: 6851934
[TBL] [Abstract][Full Text] [Related]
18. Effect of ascorbic acid on copper-induced oxidative changes in erythrocytes of individuals with a glucose-6-phosphate dehydrogenase deficiency.
Calabrese EJ; Moore GS; McCarthy MS
Bull Environ Contam Toxicol; 1983 Mar; 30(3):323-30. PubMed ID: 6850118
[No Abstract] [Full Text] [Related]
19. Low glucose-6-phosphate dehydrogenase (G-6-PD) activity in red blood cells and susceptibility to copper-induced oxidative damage.
Calabrese EJ; Moore GS; Ho SC
Environ Res; 1980 Apr; 21(2):366-72. PubMed ID: 7408807
[No Abstract] [Full Text] [Related]
20. Erythrocyte glucose-6-phosphate dehydrogenase and glutathione deficiency in sheep.
Maronpot RR
Can J Comp Med; 1972 Jan; 36(1):55-60. PubMed ID: 4258546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
